Skip to content
GLP-1 Scorecard
Menu
Graded #86

Apex MD

Apex MD is a US virtual telemedicine platform licensed in all 50 states that prescribes compounded GLP-1 medications for weight loss.

Visit Apex MDWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$299/mo
Tirzepatide
$399/mo
Coverage
All 50 states
Brand-name
Compounded only

Weigh Apex MD against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Apex MD dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value48/100
Dose & formulation83/100
Clinical oversight78/100
Labs & monitoring89/100
Fulfillment82/100
Contract terms55/100

Strengths

  • Licensed in all 50 states
  • Unlimited provider visits and Labcorp labs included in the plan
  • Both semaglutide and tirzepatide, injectable or oral
  • Medication delivery typically in under four business days

Where it loses points

  • Compounds bundle NAD, B-12 and L-Carnitine rather than a single-ingredient GLP-1
  • Does not publicly name its compounding pharmacy or list an accreditation seal

Bottom line — Grade C

Best for: People who want nationwide access to compounded glp-1 with unlimited visits and labs included.

Ranked #86 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Apex MD — the realistic shortlist.

The 20 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Apex MD's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Apex MD's site. Not medical advice; see our disclosure.

← Back to the scorecard